Indeed, such events in 11q-deletion can be further impacted on by deregulated oncogenic activities, such as MYCN amplification and aberrant ALK/MAPK signaling, resulting in normal cell development veering off-track and promoting evolution of high-risk neuroblastoma (Figure 4). Here, MYCN is linked to neuroblastoma.